February 2, 2026

We are delighted to announce that Hardip Thakerar has joined Cardiawave’s Board of Directors.
 
Hardip brings over a decade of experience in structural heart therapies and transcatheter valve innovations. She currently works at InQB8 Medical Technolgies, a medtech incubator, and has previously held senior leadership roles at Pi-Cardia, 4Tech, Twelve Inc.,Boston Scientific, and CoreValve.
 
Throughout her career, Hardip has played a pivotal role in advancing breakthrough technologies in cardiovascular care, including the development and clinical adoption of next‑generation therapies for valve disease. Her deep expertise and strategic vision will be invaluable as Cardiawave continues to advance its non‑invasive ultrasound therapy for aortic stenosis.
 
Please join us in welcoming Hardip to Cardiawave. We are excited to work with her in this new chapter as we progress into global feasibility studies, and ultimately towards commercialization.
 
@Hardip T. #Cardiawave #BoardOfDirectors #Leadership #MedTech #StructuralHeart #Innovation #AorticStenosis #CardiovascularInnovation #Valvosoft #medtech #focusedultrasound #innovation #NIUT #TAVI #TAVR #AorticValve #lifetimemanagementofas #valves
 
#FrenchCare #Health20 @france-biotech @medicen-paris-region @bpi-france @focusedultrasoundfoundation @eic-scalingclub @snitem